ShareValue scores for 603222.SHG: Valuation 43, Quality 20, Growth 45, Health 38.
603222.SHGSSE
Zhejiang Chimin Pharm Co Ltd
CN¥8.77
(+2.10%)
603222.SHGSSE
Zhejiang Chimin Pharm Co Ltd
Verdicts
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
Rating
Trap Risk
Return
Company Details
Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells in vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-pipe double-valve, single-pipe single-valve, and single-pipe double-valve soft bags; plastic bottles; and other packaging forms. It also offers injection puncture medical devices, including safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products. In addition, the company provides in vitro diagnostics products, such as clinical chemical diagnostic, immunological diagnostic, blood testing, rapid diagnostic, and enzyme-linked immunological diagnostic reagents; laboratory instruments; and in vitro diagnostic medical products, as well as FOB fecal occult blood automated immunoassay monitoring and pylori Helicobacter detection kits. Further, it offers hemodialysis series products, including hemodialysis concentrate, and other products; and medical and health services. The company was formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd. and changed its name to Chimin Health Management Co., Ltd. in August 2018. Chimin Health Management Co., Ltd. was founded in 1996 and is based in Taizhou, China. Address: No. 888, Beiyuan Road, Taizhou, China, 318020